Overview

BiomX Inc. is a clinical-stage microbiome company developing both natural and engineered phage therapies designed to target and destroy harmful bacteria in chronic diseases such as cystic fibrosis, atopic dermatitis, and colorectal cancer. The company's unique platform allows for precise targeting of bacterial pathogens, potentially revolutionizing the treatment of various conditions.

Therapeutic areas

Microbiome TherapyCystic FibrosisAtopic DermatitisColorectal Cancer

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BiomX Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this BiomX Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.